Keywords: alrt, financial, results, allergan, ligand, retinoid, therapeutic

ALRT 1995 Financial Results

Article | 08 April 1996

Print This

Allergan Ligand Retinoid Therapeutic made a net loss in the fourth quarter of 1995 of $5.2 million, or $1.61 per share. For the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in